Ward et al.
leaving groups (e.g., methoxy, hydroxy) with rate-limiting
breakdown of an equilibrium concentration of the enolate
have been observed.48 For these compounds, keto-enol
tautomerism is enhanced under conditions that minimize
the equilibrium concentration of enolate (i.e., use of weak
bases). Further, the rate of elimination from enolates of
intramolecularly hydrogen bonded aldols should be at-
tenuated because of poor π-σ* orbital overlap. Finally,
the observed influence of the base on the rates of
isomerization is difficult to accommodate. The rates of
general base-catalyzed enolization (rate-limiting abstrac-
tion of the R-C-H proton) typically increase with in-
creasing pKa of the base.21 Low basicity and steric
arguments can be invoked to account for the low reac-
tivities of pyridine (pKa 5.21) and Et3N (pKa 10.75) with
11s (Table 2), respectively. This approach seems less
appropriate to explain the much lower reactivity of
N-methylimidazole (pKa 7.06) compared to imidazole (pKa
6.95)49,50 and the reactivity of DMAP (pKa 9.2) seems to
rule out a requirement for a hydrogen bond donor.
Although imidazole and DMAP may catalyze enolization
by different mechanisms, their unique ability to catalyze
isomerization of aldols raises the possibility of nucleo-
philic catalysis.51
unavailable by direct methods (e.g., 11a , 21a s, and 22ss).
Although the equilibrium ratios are typically modest,
synthetically useful amounts of material can be obtained
by recycling if necessary.
Exp er im en ta l Section 53
(3S)-r el-3-[(R)-(6R)-1,4-Dioxa -8-th ia sp ir o[4.5]d ec-6-yl-
(h yd r oxy)m eth yl]tetr a h yd r o-4H-th iop yr a n -4-on e (11a ).
Crystallization of the crude product from aldol reaction of 10
(3.47 g, 18.5 mmol) and the trimethylsilyl enol ether of 8 (7.00
g, 37.0 mmol) in the presence of MgBr2‚OEt2 (14.3 g, 55.4
mmol) as previously described18 gave solid 11s (3.49 g, 62%)
and a mother liquor containing a ca. 5:1 mixture of 11a /11s.
A solution of the solid 11s (3.49 g, 11.5 mmol) and imidazole
(6.8 g, 0.10 mol) in CH2Cl2 (100 mL) was allowed to stand for
24 h. The mixture was washed with aqueous citric acid (0.2
M) and the aqueous layer extracted with CH2Cl2. The com-
bined organic layers were dried over Na2SO4 and concentrated
to give a 2:1 mixture of 11s/11a (3.40 g, 98%). Crystallization
of the mixture from methanol gave solid 11s (2.08 g, 61%) and
a mother liquor containing a ca. 8:1 mixture of 11a /11s. The
solid 11s (2.08 g) was subjected to isomerization as above to
give solid 11s (1.22 g, 58%) and a mother liquor containing a
ca. 6:1 mixture of 11a /11s. The combined mother liquors from
the above crystallizations (3) (4.1 g; a 6:1 mixture of 11a /11s)
were fractionated by MPC (25-50% ethyl acetate in hexane)
to give 11s (437 mg; a total of 1.66 g of 11s isolated, 30%
overall from 10) and 11a (2.88 g, 51% from 10). Spectral data
was identical to that reported previously.18
Con clu sion
(3R,5S)-r el-3,5-Bis[(S)-(6R)-1,4-d ioxa -8-t h ia sp ir o[4.5]-
d e c-6-ylh yd r oxym e t h yl]t e t r a h yd r o-4H -t h iop yr a n -4-
on e (21a s). Bisaldol 21a a (13 mg, 0.026 mmol) was added to
a solution of imidazole (136 mg, 2.00 mmol) in CH2Cl2 (2.0 mL).
After 20 h at room temperature, the mixture was diluted with
aqueous citric acid (0.1 M) and extracted with CH2Cl2 (×3).
The combined organic layers were dried over Na2SO4 and
concentrated to give a 6.2:3:1 mixture (12 mg) of 21a s, 21a a ,
and 21ss, respectively. Fractionation of the mixture by PTLC
(2% MeOH in CH2Cl2; multiple elution) gave 21ss (1.5 mg,
12%), 21a a (3.5 mg, 27%), and the titled compound (6 mg,
46%): IR (DRIFT) νmax 3518, 2917, 1694, 1427, 1153, 1131,
1101, 1042 cm-1; 1H NMR (500 MHz, C6D6) δ 4.69 (1H, ddd, J
) 1.5, 3.5, 6 Hz, HC-1′), 4.17 (1H, ddd, J ) 3.5, 7.5, 10 Hz,
HC-1′′), 3.45-3.24 (6H, m, H2CO × 4), 3.24-3.02 (9H, m,
H2CO, HC-2, HC-3, HC-5, HC-6, HC-7′, H2C-7′′), 3.13 (1H, d,
J ) 1.5 Hz, HOC-1′), 2.85 (1H, dd, J ) 11.5, 13 Hz, HC-2 or
HC-6), 2.77 (1H, d, J ) 10 Hz, HOC-1′′), 2.72 (1H, br d, J )
13.5 Hz, HC-7), 2.58 (1H, m, J ) 4, 8, 13 Hz, HC-9′′), 2.52
(1H, ddd, J ) 3.5, 3.5, 13 Hz, HC-2 or HC-6), 2.49 (1H, ddd, J
) 3, 10.5, 13.5 Hz, HC-9′), 2.25-2.24 (2H, m, HC-9′, HC-9′′),
2.21 (1H, ddd, J ) 3.5, 4, 9.5 Hz, HC-6′), 2.16 (1H, ddd, J )
3.5, 7, 7.5 Hz, HC-6′′), 1.63 (1H, ddd, J ) 3, 6, 13.5 Hz, HC-
10′), 1.48 (1H, ddd, J ) 3.5, 10.5, 13.5 Hz, HC-10′), 1.45-1.36
(2H, m, H2C-10′′); (500 MHz, CDCl3) δ 4.53 (1H, br d, J ) 8.5
Hz, HC-1′), 4.17-3.89 (9H, m, HC-1′′, H2CO ×4), 3.33 (1H,
ddd, J ) 3.5, 4, 13.5 Hz, HC-2), 3.27 (1H, ddd, J ) 3.5, 3.5, 12
Hz, HC-5), 3.21 (1H, dd, J ) 12, 13 Hz, HC-6), 3.10 (1H, d, J
) 1 Hz, HOC-1′), 3.09-2.50 (9H, m, HC-3, H2C-7′, H2C-7′′,
H2C-9′, H2C-9′′), 2.97 (1H, d, J ) 9.5 Hz, HOC-1′′), 2.91 (1H,
ddd, J ) 3, 3.5, 13 Hz, HC-6), 2.85 (1H, dd, J ) 11.5, 13.5 Hz,
HC-2), 2.22 (1H, ddd, J ) 3, 7.5, 7.5 Hz, HC-6′′), 2.16-2.07
(2H, m, HC-6′, HC-10′ or HC-10′′), 1.88 (1H, ddd, J ) 3,
8.5, 13.5 Hz, HC-10′ or HC-10′′), 1.78-1.71 (2H, m, HC-10′,
HC-10′′); 13C NMR (125 MHz, CDCl3) δ 215.5 (s), 110.2 (s),
109.0 (s), 70.9 (d, C-1′), 66.9 (d, C-1′′), 64.9 (t), 64.8 (t), 64.3
(t), 64.0 (t), 57.5 (d), 57.0 (d), 47.5 (d), 46. (d), 37.1 (t), 35.8 (t),
35.5 (t), 34.6 (t), 29.3 (t), 26.8 (t), 26.7 (t), 26.6 (t); LRMS (EI)
m/z (relative intensity) 492 ([M]+, 1), 304 (8), 188 (15), 159
In conclusion, imidazole has been shown to be a very
effective catalyst for syn-anti isomerization of aldols via
an enolization mechanism. DMAP is also effective isomer-
ization catalyst but the lower basicity, molecular weight,
and cost per mole of imidazole justify its preferential use
for most substrates. The process is applicable to a broad
range of substrates52 and is particularly facile for tet-
rahydro-4H-thiopyran-4-on-derived aldols. The presence
of the aldol hydroxy group greatly facilitates isomeriza-
tion but has only a small effect on enolization regio-
selectivity. Most substrates reach equilibrium within
0.3-3 days at ambient temperature in chloroform or
benzene containing 0.3-1 M imidazole. A more rapid
equilibration can be achieved with gentle warming but
the generality of this approach was not examined.
Isomerizations are high yielding and occur with little or
none of the usual byproducts arising from competing
elimination or retroaldol reactions even after prolonged
reaction. Consequently, this isomerization process can
provide convenient synthetic access to diastereomers
(48) Methoxy-2-butanone,41d cis-octahydro-8a-hydroxy-4a-methyl-
2(1H)-naphthalenone,41h and prostaglandin E241k (note: intramolecular
hydrogen bonding is not possible for these aldols).
(49) The rate constants for imidazole- and N-methylimidazole-
catalyzed enolizations of â-oxy ketones were very similar (see ref 41g
and h).
(50) For imidazole-catalyzed enolization of acetone, see: (a)
Mel’nichenko, I. V.; Yasnikov, A. A. Ukr. Khim. Zh. 1964, 30, 723-
728. (b) Bender, M. L.; Williams, A. J . Am. Chem. Soc. 1966, 88, 2502-
2508. For a discussion of the possibility of imidazole acting as a
bifunctional enolization catalyst, see refs 41g, 51a, and: (c) Banks, B.
E. C. J . Chem. Soc. 1962, 63-71. (d) Breslow, R.; Graff, A. J . Am.
Chem. Soc. 1993, 115, 10988-10989.
(51) (a) Bruice, P. Y.; Bruice, T. C. J . Am. Chem. Soc. 1978, 100,
4793-4801. (b) Bruice, P. Y. J . Am. Chem. Soc. 1983, 105, 4982-4996.
(c) Bruice, P. Y. J . Am. Chem. Soc. 1990, 112, 7361-7368.
(52) For other examples, see: (a) Notz, W.; Tanaka, F.; Watanabe,
S.; Chowdari, N. S.; Turner, J . M.; Thayumanavan, R.; Barbas, C. F.
J . Org. Chem. 2003, 68, 9624-9634. (b) Williamson, R. T.; Marquez,
B. L.; Sosa, A. C. B.; Koehn, F. E. Magn. Reson. Chem. 2003, 41, 379-
385.
(53) See the Supporting Information for general methods and
procedures.
4814 J . Org. Chem., Vol. 69, No. 14, 2004